Shares of Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) were up 6.3% during trading on Friday . The company traded as high as $12.31 and last traded at $12.31. Approximately 1,301 shares were traded during trading, an increase of 180% from the average daily volume of 464 shares. The stock had previously closed at $11.58.
Sumitomo Pharma Stock Performance
The company’s fifty day simple moving average is $9.60 and its two-hundred day simple moving average is $7.09.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co, Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia.
Read More
- Five stocks we like better than Sumitomo Pharma
- ESG Stocks, What Investors Should Know
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
